Concepedia

Valentina Giai

VG

Statistics

Publications

22

Citations

2K

H-Index

18

Active since

2007

Affiliations

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Turin

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

Valentina Giai is an author at Azienda Ospedaliera Citta' della Salute e della Scienza di Torino specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2007–2024

22

Publications

22

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti et al. · New England Journal of Medicine · 2020 · 519 citations · Full text

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · New England Journal of Medicine · 2020 · 403 citations · Full text

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 252 citations · Full text

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts

Maryam Nikpour, Christian Scharenberg, Anquan Liu et al. · Leukemia · 2012 · 99 citations

, , +7

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · Blood · 2019 · 97 citations

1–5 of 22